<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3D101616-CA8D-47BE-95E3-A8D7CE62A02B"><gtr:id>3D101616-CA8D-47BE-95E3-A8D7CE62A02B</gtr:id><gtr:name>North West University</gtr:name><gtr:address><gtr:line1>Potchefstroom Campus</gtr:line1><gtr:line2>Private Bag X6001</gtr:line2><gtr:postCode>2520</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2C1C85FB-77AC-4019-9363-4A2E4A909E16"><gtr:id>2C1C85FB-77AC-4019-9363-4A2E4A909E16</gtr:id><gtr:name>Cardiff &amp; Vale University Health Board</gtr:name><gtr:address><gtr:line1>Heath Park</gtr:line1><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF14 4XW</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FD1D5D34-47B1-4EB0-910E-E91B7E4445F0"><gtr:id>FD1D5D34-47B1-4EB0-910E-E91B7E4445F0</gtr:id><gtr:name>National Institute on Aging (NIA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>School of Medicine</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5EE55E7A-9A75-4570-A04D-D9F36C3129EC"><gtr:id>5EE55E7A-9A75-4570-A04D-D9F36C3129EC</gtr:id><gtr:name>National Institutes of Health</gtr:name><gtr:address><gtr:line1>31 Center Drive</gtr:line1><gtr:line2>9000 Rockville Pike</gtr:line2><gtr:postCode>20892</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3D101616-CA8D-47BE-95E3-A8D7CE62A02B"><gtr:id>3D101616-CA8D-47BE-95E3-A8D7CE62A02B</gtr:id><gtr:name>North West University</gtr:name><gtr:address><gtr:line1>Potchefstroom Campus</gtr:line1><gtr:line2>Private Bag X6001</gtr:line2><gtr:postCode>2520</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/86BA0D2C-1895-41C5-B18C-092178DFFB3E"><gtr:id>86BA0D2C-1895-41C5-B18C-092178DFFB3E</gtr:id><gtr:name>National Institute for Health Research</gtr:name><gtr:address><gtr:line1>NIHR Clinical Research Network CC</gtr:line1><gtr:line2>Fairbairn House</gtr:line2><gtr:line3>71-75 Clarendon Road</gtr:line3><gtr:postCode>LS2 9PH</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2C1C85FB-77AC-4019-9363-4A2E4A909E16"><gtr:id>2C1C85FB-77AC-4019-9363-4A2E4A909E16</gtr:id><gtr:name>Cardiff &amp; Vale University Health Board</gtr:name><gtr:address><gtr:line1>Heath Park</gtr:line1><gtr:line4>Cardiff</gtr:line4><gtr:postCode>CF14 4XW</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/47977EA7-B9F8-4D02-9BD2-FD4D34F2644D"><gtr:id>47977EA7-B9F8-4D02-9BD2-FD4D34F2644D</gtr:id><gtr:name>Genomics England</gtr:name><gtr:address><gtr:line1>Queen Mary University of London</gtr:line1><gtr:line2>Dawson Hall</gtr:line2><gtr:line3>Charterhouse Square</gtr:line3><gtr:postCode>EC1M 6BQ</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FD1D5D34-47B1-4EB0-910E-E91B7E4445F0"><gtr:id>FD1D5D34-47B1-4EB0-910E-E91B7E4445F0</gtr:id><gtr:name>National Institute on Aging (NIA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/7801F008-7C77-45E7-90E9-4345B47D138E"><gtr:id>7801F008-7C77-45E7-90E9-4345B47D138E</gtr:id><gtr:name>University of Plymouth</gtr:name><gtr:address><gtr:line1>Drake Circus</gtr:line1><gtr:line4>Plymouth</gtr:line4><gtr:line5>Devon</gtr:line5><gtr:postCode>PL4 8AA</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/85D807DF-0780-4EA3-B61C-036EBF025B49"><gtr:id>85D807DF-0780-4EA3-B61C-036EBF025B49</gtr:id><gtr:firstName>Huw</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Morris</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0700943"><gtr:id>27A34A9B-BFE0-4B80-968E-2FEBC197F2B9</gtr:id><gtr:title>Genome wide analysis of Young Onset Parkinson disease in Wales</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700943</gtr:grantReference><gtr:abstractText>Parkinson disease (PD) involves wearing down of brain cells, which leads to tremor and slowness of movement. At the moment there are no treatments which prevent the damage to nerve cell function. Although PD is not usually a familial disease we now know that genetic variation can be important in some patients. This is probably particularly important in people who develop PD at a young age. 

The genetic code contains the information which controls the development and function of all the cells in the body and variation in this code can increase the risk of developing disease. 

We have access to new technology (DNA chips) which allows the measurement of a large number of DNA variants (over 550,000) every 5000 letters, through the entire human genome. We will use these chips to map variation that occurs frequently in patients with young onset PD in an attempt to discover new genes that can cause PD. 

This information will be useful for the diagnosis of PD and in advising patients on the risk to family members. Ultimately we hope that the identification of the disease pathway, through disease genes, will lead to new treatments.</gtr:abstractText><gtr:technicalSummary>Parkinson disease (PD) is a common age dependant neurodegenerative disease and about 5% of PD patients develop disease before the age of 45. Epidemiological data suggest that many patients with Young Onset PD have autosomal recessive disease. To date, three autosomal recessive genes for PD have been identified, parkin, DJ-1 and PINK-1 but together these genes account for no more than 25% of young onset European PD patients. Mutations identified in parkin, in the non-consanguineous European population include homozygous point mutations and exonic deletions and multiplications. We believe that patients with Young Onset PD are an extremely important resource for understanding the development of PD, and that there are further genes to be identified in this group. We have established a community-based study of Young Onset PD in Wales. This stable and relatively homogenous outbred population has great advantages for genetic analysis - we predict that there will be a restricted number of mutations responsible for PD in the Welsh group. We propose genome wide single nucleotide polymorphism analysis (using the Illumina HumanHap550 chip) in 75 Welsh young onset PD patients and 75 Welsh controls, following preliminary analysis of known PD genes. The Illumina genotyping chip used contains over 550,000 SNPs spaced on average every 5.5 kb across the genome. In addition to the A/B genotype assignment, metrics generated in the chip analysis can be used to determine the presence of genomic deletions and duplications. This analysis will be undertaken in collaboration with Dr. Andrew Singleton laboratory at the US National Institutes of Health, who have carried out similar analysis on late onset PD sample sets. The identification of common non-polymorphic variation in Welsh young onset PD patients will be used to map novel disease genes. Candidate genes will be analyzed in further detail in our large PD cohort which by the end of 2007 will include over 400 PD patients, and in collaboration with Dr. Andrew Singleton using their PD patient sample. This novel approach to mapping disease genes will lead to new insights into the pathogenesis of PD, which in the long term will pave the way for new disease modifying therapies. More immediately, identifying new genes for PD will improve our understanding of the disease nosology, genetic counseling and 
will lead to the development of new diagnostic and predictive tests.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-04-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>202817</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute on Aging (NIA)</gtr:department><gtr:description>NIAGADS data request</gtr:description><gtr:id>BE3BF8B1-D9E4-4458-B530-13D8A6AE188A</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:partnerContribution>Access to large datasets of human genomic and phenotypic data generated by NIA supported grants and cooperative agreements and/or NIA funded biological samples.</gtr:partnerContribution><gtr:piContribution>Analysis of combined clinical data from the NIA Genetics of Alzheimer's Disease Data Storage Site (NIAGADS).</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Institute of Neurology</gtr:department><gtr:description>UK PD WTCCC2 Consortium</gtr:description><gtr:id>5F0AC4A8-E3F9-4BC0-95F8-275981FBEEAF</gtr:id><gtr:impact>Obtained follow on funding from Parkinson's disease society for replication and data analysis 
Primary UK PD GWAS paper - published in Human Molecular Genetics</gtr:impact><gtr:partnerContribution>We have collaborated in the whole genome genotyping of approximately 2000 UK Parkinson's disease subjects. The data derived from this is being used to supplement the primary analysis in the MRC grant and this has lead on to further follow on funding for the consortium from the Parkinson's disease society.</gtr:partnerContribution><gtr:piContribution>We have contributed samples from PD patients and are collaborating in the analysis of autozoygosity, copy number variants and gene pathway analysis in these datasets.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>D9F36B19-AB63-4A43-B8F3-CBDEB2A9D12E</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>7781C862-5A27-41E4-8FE2-E1CD0F821D9C</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>E88A1323-45CD-4620-AF0C-E7957E1266C0</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>University College London Hospitals Charity (UCLH)</gtr:department><gtr:description>Collaboration with NHS Neurogenetics UCLH</gtr:description><gtr:id>1B6212B4-3F81-44A6-9297-4185A29A661F</gtr:id><gtr:impact>-</gtr:impact><gtr:partnerContribution>Provision of NHS genetic testing</gtr:partnerContribution><gtr:piContribution>Developing NHS testing for PD and following up on NHS patients</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genomics England</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration wth Genome England Limited</gtr:description><gtr:id>5E1CBB49-FB6D-4434-9974-C1800041B6B4</gtr:id><gtr:impact>No outputs as yet</gtr:impact><gtr:partnerContribution>Family recruitment - will involve analysis of data and correlation with clinical and para-clinical measures</gtr:partnerContribution><gtr:piContribution>Recruitment of Early Onset PD families for whole genome sequencing</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff and Vale University Health Board (Bwrdd Iechyd Prifysgol Caerdydd a'r Fro)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>University Hospital of Wales</gtr:department><gtr:description>Collaboration with Institute of Medical Genetics, University Hospital of Wales, Cardiff</gtr:description><gtr:id>083D3A6B-ED08-4CD5-8E45-BE4B1C638603</gtr:id><gtr:impact>Our collaboration with the NHS Medical Genetics Service in Cardiff has led to the development and service provision of NHS based diagnostic and predictive testing for mutations in parkin and LRRK2
We have also published on other Mendelian conditions including Alzheimer disease, Fronto-temporal dementia and Amyotrophic lateral sclerosis</gtr:impact><gtr:partnerContribution>identification of potential research collaborators via users of the NHS service</gtr:partnerContribution><gtr:piContribution>In collaboration with the NHS Medical Genetics Service in Cardiff we have worked on the development and provision of genetics testing for parkin and LRRK2 - we have worked on the preparation for the submission to the UK Genetic Testing Network</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging (NIA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Neurogenetics</gtr:department><gtr:description>Chromosome 9 MND</gtr:description><gtr:id>C3BA80F5-A113-496C-B754-D218FCC176CC</gtr:id><gtr:impact>Publications/filing the patent/NHS for MND developed/Follow on grant from MND Association/talk for patients' group</gtr:impact><gtr:partnerContribution>Genetic analysis</gtr:partnerContribution><gtr:piContribution>Clinical/pathological/cell biology/genetic analysis</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institutes of Health (NIH)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>National Institute on Aging (NIA)</gtr:department><gtr:description>International Consortium for PD Genetics</gtr:description><gtr:id>0B85BA49-F050-443A-A0F1-F35AB81C5CA3</gtr:id><gtr:impact>Meta-analysis of data reveals 11 loci for late onset PD; manuscript submitted to Lancet
Part of this collaboration includes the collaborative analysis of Copy Number Variants and Homozygosity Mapping in Early Onset PD within the same consortium</gtr:impact><gtr:partnerContribution>Pooling of data - allowing large scale analysis of homozygosity in PD and identification of novel loci for late onset PD</gtr:partnerContribution><gtr:piContribution>Collaboration with Holland, Germany, France and US in the further analysis of Genome Wide Association Studies in PD</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Plymouth - PD-STAT study</gtr:description><gtr:id>715C47BE-C50E-4280-9602-034965E45AA0</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:partnerContribution>Collection of DNA samples and clinical data</gtr:partnerContribution><gtr:piContribution>The study investigates the potential of simvastatin to slow or halt the progression of Parkinson's disease. This research team has contributed by organising the addition of a genetics sub-study to the main clinical trial.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>North-West University</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>South African PD sample sharing</gtr:description><gtr:id>B0F24AC3-1192-4EFD-B20D-C1984D72F355</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:partnerContribution>Collection and sharing of DNA and clinical data from early onset and familial Parkinson's/ parkinsonism patients.</gtr:partnerContribution><gtr:piContribution>Genotyping of PD samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Division of Medicine</gtr:department><gtr:description>Chromosome 9 MND</gtr:description><gtr:id>67647E7E-B92F-444A-8FD0-6F04C46B8BCD</gtr:id><gtr:impact>Publications/filing the patent/NHS for MND developed/Follow on grant from MND Association/talk for patients' group</gtr:impact><gtr:partnerContribution>Genetic analysis</gtr:partnerContribution><gtr:piContribution>Clinical/pathological/cell biology/genetic analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Health Research (NIHR)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with National Institute of Health Research (NIHR)</gtr:description><gtr:id>DD328F20-8DF4-4A6D-B205-164D48D649CE</gtr:id><gtr:impact>This collaboration has resulted in increased recruitment and improved delivery to both the 100,000 Genomes Project, the Parkinson's Families Project, and other studies within the NIHR portfolio. Staff from both Genomics England Project and NIHR CRN collaborate closely to optimise recruitment, and can be trained to recruit in a variety of studies.

The NIHR Research Capability Funding has also enabled extension of the Research Assistant post, allowing recruitment to continue into 2017.</gtr:impact><gtr:partnerContribution>The NIHR Clinical Research Network have provided nurse and staff support for recruitment at hospitals around the UK. In addition, the NIHR have supported staff salary costs for the research assistant position at the Royal Free Hospital by awarding Research Capability Funding in 2016 and 2017.</gtr:partnerContribution><gtr:piContribution>Our research team has contributed to NIHR recruitment by recruiting to the Parkinson's Families Project, which is adopted on the NIHR portfolio of studies. Increased recruitment assists with allocation of funding to sites and networks within the NIHR.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Birmingham</gtr:collaboratingOrganisation><gtr:country>Unknown</gtr:country><gtr:department>Birmingham Clinical Trials Unit</gtr:department><gtr:description>Collaboration with Birmingham PD-MED</gtr:description><gtr:id>7DB3BB61-F8AC-446A-941E-7ACB146E2C37</gtr:id><gtr:impact>None so far.</gtr:impact><gtr:partnerContribution>Approximately 2000 participants recruited through more than 80 neurology and care of the elderly units throughout the UK.</gtr:partnerContribution><gtr:piContribution>A collaborative study involving large randomised assessment of the relative clinical and cost-effectiveness of classes of drugs for Parkinson's disease. Sharing of samples and data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neuroscience and Psychology</gtr:department><gtr:description>Google Genomics Consortium</gtr:description><gtr:id>87EC6D3A-643E-4961-A5F3-ECCE88438E6D</gtr:id><gtr:impact>Approval from relevant UK Research Ethics Committees, circulation and sign-off of Memorandum of Understanding from partner universities.</gtr:impact><gtr:partnerContribution>Contribution of samples and exome sequencing data</gtr:partnerContribution><gtr:piContribution>Upload of exome sequencing data to Google Cloud, coordination of sign-off on Memorandum of Understanding and research ethics committee approvals.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Plymouth</gtr:collaboratingOrganisation><gtr:country>Unknown</gtr:country><gtr:department>Peninsula College of Medicine and Dentistry (PCMD)</gtr:department><gtr:description>Collaboration with Plymouth - Molecular Genetic Studies of Neurodegenerative Disorders</gtr:description><gtr:id>14B8E8AD-70C7-4F68-B5ED-6710A7080BC9</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:partnerContribution>Recruitment and collection of samples for over 2000 participants within the UK.</gtr:partnerContribution><gtr:piContribution>A collaborative study involving the collection and storage of DNA and protein samples from patients in comparison to participants without Parkinson's. This research team contributed through genotyping of samples and follow up of participants to collect key clinical data.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Glasgow</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PROBAND</gtr:description><gtr:id>8AFB9962-ABBA-4830-A7F5-40D4BBD39AF3</gtr:id><gtr:impact>None so far</gtr:impact><gtr:partnerContribution>Organisation and collection of samples over 50 sites in UK</gtr:partnerContribution><gtr:piContribution>A collaborative study of the genetics of Parkinson's disease following 2240 UK patients with PD. Arranging and carrying out genotyping.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Positive Steps in Parkinson's Disease (Manchester)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8206C48C-EA2A-4E85-9F4C-A92BF686194D</gtr:id><gtr:impact>Invited speaker, presented talk on 'Top tips for the management of the patient with atypical parkinsonism'.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MND Meeting</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>29B6DA39-556E-4128-9946-D8F2A8A89AF1</gtr:id><gtr:impact>UK consortium for Chromosome 9

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>European Academy of Neurology Symposium (Berlin)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>706D9239-76BE-42FD-AE4F-BBF8B35B1405</gtr:id><gtr:impact>Attended the EAN Neurology Symposium in Berlin which included presentations, teaching courses, hands-on-courses, focused workshops and interactive sessions. Topics included:
- Preclinial neurological diseases
- Expanding fields in neurology
- Modern molecular genetics
- Present and future treatment in movement disorders</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CurePSP 2016 International Research Symposium (New Jersey)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C2550D17-228A-4C9B-B35E-41735F441774</gtr:id><gtr:impact>CurePSP conducts an annual International Research Symposium that brings together international investigators to hear about and discuss the latest advances in prime of life neurodegeneration including PSP, CBD, MSA and related diseases. The Symposium highlighted research by CurePSP grantees. The Research Symposium also assisted the CurePSP Scientific Advisory Board (SAB) in identifying work of exceptional promise, which may then be considered for additional funding. Presentations covered: cell biology research, genetics research, clinical trials, diagnostic criteria and therapeutic opportunities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cure Parkinson's Trust Research Meeting 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>49A3099E-B9CE-4175-8C57-510A3BF240FC</gtr:id><gtr:impact>Two research team members delivered brief presentations at the Cure Parkinson's Trust research meeting, to approximately 100 patients, carers and key personnel within Cure Parkinson's Trust. Information about current research trials and planned studies was presented.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK website information for the Parkinson's Families Project</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>27B3EF4A-E4A4-4A80-9596-F69198F91A0F</gtr:id><gtr:impact>Parkinson's UK have provided summary information about the Parkinson's Families Project on their website. Many potential participants have contacted the research team as a result of seeing this page or hearing about the study through Parkinson's UK&amp;gt;</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>https://www.parkinsons.org.uk/content/take-part-parkinsons-research-list-uk-studies</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Society of Physicians in Wales Spring Meeting (Portmeirion)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0DE03D83-6F9E-407F-8C66-6EB9B2350FD4</gtr:id><gtr:impact>Meeting of the Society of Physicians in Wales that included sessions on the future of hospitals commission and impact on working practices, and chief resident programme. Attendees shared and furthered their knowledge of acute and general medicine.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation at the UCL Basal Ganglia Club (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AB8DBEBD-C11D-4757-A1D6-A9C081AA27B4</gtr:id><gtr:impact>Presented talk at Basal Ganglia Club to clinicians and researchers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Molecular Neurology and Therapeutics course (Cambridge/New York)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AE72149C-59CF-4845-A3DE-0603FFF7CA33</gtr:id><gtr:impact>Invited speaker at the Molecular Neurology and Therapeutics course, organised by Wellcome Trust

Taught attendees the latest concepts and methodologies associated with the study of human neurological disorders including Parkinson's disease. Generated discussion about the strengths and weaknesses of the accumulated experimental evidence underlying our current understanding of neurological diseases and how this knowledge can be applied to developing therapeutic approaches.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2008,2009,2010,2011,2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>YPN Magazine</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FBF7D522-6D6F-4D12-BF6F-A01FAFDC1362</gtr:id><gtr:impact>Piece on our research for Younger Parkinson's Group Newsletter

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at International Parkinson's Disease and Movement Disorders Conference (Sydney)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>189084E0-1690-476B-AD27-0486D5E8C5F4</gtr:id><gtr:impact>The Conference brought together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Parkinson's Disease and Movement Disorders. It provided a forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Parkinson's Disease and Movement Disorders.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Free Hospital Neurosciences meeting (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9BC8A172-45DD-4D10-AB67-6DB053828966</gtr:id><gtr:impact>Presented a talk at the RFH Neurosciences meeting to trainees and consultants to promote the 100,000 Genomes Project. This successfully generated interest in the research study and increased the number of local referrals for the project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust Molecular Neurodegeneration course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7FF0F811-3325-4640-8165-0190972D7BDB</gtr:id><gtr:impact>This highly-regarded course provided a cutting edge examination of the molecular basis of neurodegeneration and the development of treatment strategies. Many parallels are evident between different neurodegenerative diseases and this course highlighted and discussed, in detail, the common themes across neurodegenerative processes. Course participants gained an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental evidence and how this knowledge can be applied to develop therapies.

Course topics included:
? Pathological events in human neurodegeneration
? Development of therapeutic approaches
? Genetic variation in inherited and sporadic disease
? Role of pathogenic proteins 
? Use of in vivo models to study neurological pathogenesis
? The application of high content approaches
? Genome editing: methods and applications</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hay Festival - What is dementia?</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>305E9D93-57B7-4EDE-BBEF-F1A9053BC839</gtr:id><gtr:impact>Lecture to 400 members of public at Hay Literary Festival

http://www.walesonline.co.uk/news/health-news/2012/06/07/leading-the-fight-against-dementia-in-wales-91466-31133563/</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.walesonline.co.uk/news/health-news/2012/06/07/leading-the-fight-against-dementia-in-wales-91466-31133563/</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Progressive Supranuclear Palsy Research Event (Durham)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>883910A5-7D7D-46F0-A216-717C2925DBE4</gtr:id><gtr:impact>The psychology department at Durham University, in collaboration with South Tees NHS Trust, organised the event for academics, clinicians, patients and carers to discuss research relating to PSP. The all-day event involved presentations from healthcare professionals and the PSP network on topics including what's new in PSP, symptom control, and care planning. There were also workshop sessions to develop new research ideas.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CurePSP Symposium (San Francisco)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>0F5C2226-0A4A-40E2-9709-57866EE8DBDF</gtr:id><gtr:impact>CurePSP conducts an annual International Research Symposium that brings together international investigators to hear about and discuss the latest advances in prime of life neurodegeneration including PSP, CBD, MSA and related diseases. The Symposium highlighted research by CurePSP grantees. The Research Symposium also assisted the CurePSP Scientific Advisory Board (SAB) in identifying work of exceptional promise, which may then be considered for additional funding. Presentations covered: cell biology research, genetics research, clinical trials, diagnostic criteria and therapeutic opportunities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Younger Parkinsons Network Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>318CAFFD-D9BB-4778-80DD-1402BBD6F9DC</gtr:id><gtr:impact>Presented on our research to UK Younger onset Parkinson's group Stratford

Not Known</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Families Projects website</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>92B880C8-BAA8-4210-A964-ABE90FF8C41F</gtr:id><gtr:impact>The PFP website is designed for members of the public, patients and participants to receive essential information about the research project. The website features comments and experiences of patients with Parkinson's, and information on how to get in contact with the research team.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.parkinsonsfamiliesprojects.com/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Disease Nurse Specialist Association conference (Coventry)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E7749FEE-F3B8-433F-89D3-51C01E2E7615</gtr:id><gtr:impact>Presented at the annual Parkinson's Disease Nurse Specialist National two day conference in Coventry. Topics included:
Key Note Speaker - Pain
The Mental Maze
Parkinson's Excellence Network Update
Including underserved and minority groups in Parkinson's (Prof R. Walker)
Dragons Den - Hot topics / Innovations / Hot off the press
Case Presentations - Difficult / Interesting Cases
Things That Go Bump in the night
Neurological Examination
Tip of the Iceberg - Differential Diagnosis
Sticks and Stones - Falls and Fracture Risk</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PD-STAT/ Cure Parkinson's Trust meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8315C0E8-2100-4C60-B312-AE768A98E597</gtr:id><gtr:impact>A joint event was organised by the Cure Parkinson's Trust and Plymouth University Clinical Trials unit. The purpose of the meeting was to outline the aims and processes of the PD-STAT (Simvastatin as a neuroprotective treatment for Parkinson's disease) clinical trial to patients and investigators. Members of our research team delivered presentations on linked Parkinson's research studies and made contact with potential participants. This event successfully generated interested in the PD-STAT study and related Parkinson's research studies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Families Project patient meeting</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>90A922D4-72E0-45C0-8A5F-866E73B08CB6</gtr:id><gtr:impact>A small panel met with a PD patient to go discuss a draft Participant Information Sheet, receiving helpful feedback and opinions from the patient.

The meeting was very productive and generated positive feedback about the draft information sheet. It also provided helpful feedback which influenced later versions of study material.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Research Syposium CurePSP (California)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1CE40E71-7A9C-4BEC-9A2F-C0CA0E2AC29D</gtr:id><gtr:impact>The focus of this symposium, organised by CurePSP, was 'Unlocking the secrets of brain disease'. Researchers, academics and clinical practitioners presented results and debated on specialised discussion panels, including the topics of:
- Genetics and Epigenetics
- Clinical Trials</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK Royal College of Physicians Research Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AA57B873-2F10-46A9-ACBB-D63E3BC0AC44</gtr:id><gtr:impact>This event was organised by Parkinson's UK for patients and the general public. The theme of the presentation was: Parkinson's and Genetics - Unlocking the next generation of treatments. Researchers discussed:
Rare changes to our genes that can cause the condition
How genetics research has progressed in other neurological conditions and how we can emulate this for Parkinson's
The different areas of treatments that are emerging in the field of genetics</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Excellence Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0985A64F-C869-45B0-B26B-04FFD3B2C62F</gtr:id><gtr:impact>Prof Huw Morris presented a talk at the Parkinson's Excellence Network London meeting at the Royal Free Hospital, held on the 28th January 2016. The purpose of this meeting was for the working groups to report back on currently ongoing work and results, as well as identified difficulties and challenges, and to bring the working groups together to discuss further steps. 
Attendees included: Patients, Neurologists, Geriatricians, Parkinson's disease nurse specialists (PDNS), Researchers, Psychologists, Psychiatrists, Speech and Language Therapists (SLT), Occupational Therapists (OT), Physiotherapists (PT), Trainees and a Clinical Commissioner.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Independent Doctors Federation Spring Symposium (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B20AC211-EF91-4B13-9AB4-514E02EC06CE</gtr:id><gtr:impact>Prof Morris presented a talk at the Independent Doctors Federation Spring Symposium 'Neurology Today and Tomorrow'.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk at Southampton</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>D48B8E0A-5C04-48F2-BF40-DC4DBBE08A90</gtr:id><gtr:impact>Delivered a talk at Southampton Hospital</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PRoBaND investigator meeting 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0D939EA6-8C1F-4B5B-AA74-FBDC53954D20</gtr:id><gtr:impact>This meeting with PRoBaND investigators and study teams from across the UK provided the opportunity to discuss analysis plans and present data.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LWENC Annual Symposium (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>582B2A17-1DD6-4AB4-A3D8-9D751A97A920</gtr:id><gtr:impact>Prof Morris presented a talk and members of the research team attended the symposium titled 'Neurodegeneration: Using genetics to understand pathogenesis and facilitate early diagnosis', hosted by the Leonard Wolfson Experimental Neurology Centre.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Excellence Network</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A190B6E-6481-4928-9FFE-E2F3D60FAD9E</gtr:id><gtr:impact>The UK Parkinson's Excellence Network brings together health and social care professionals to transform care for people affected by Parkinson's. The Network will:
- enable professionals to work together for change
- build an expert workforce
- equip professionals to influence services
- strengthen the voice of people affected

The Network offers resources to support service improvement and engage people affected by Parkinson's, comprehensive information about education and training and collaboration opportunities.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.parkinsons.org.uk/professionals/about-excellence-network</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Parkinson's UK Research Conference: 100,000 Genomes Project</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BD5B15EA-80D5-4D28-9C1E-C4FFD4DB4175</gtr:id><gtr:impact>Our research nurse presented a poster at the Parkinson's UK Research Conference 2016, presenting recruitment and baseline data from the 100,000 Genomes Project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal College of Psychiatrists - PSP</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>3711DC67-A1A0-4BE7-857F-1132E1A00832</gtr:id><gtr:impact>Invited speaker on PSP to Royal College of Psychiatrists

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Committee - PSP</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>05C2625B-E528-4C50-8409-747F7FFA6309</gtr:id><gtr:impact>Developing Care Standards for PSP

http://www.pspeur.org/care_pathway/</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biomedical Research Advisory Panel (BRAP) meeting Motor Neurone Disease Association (MNDA)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>0A18626A-0597-4FB5-81EA-BE8B1A5C62B0</gtr:id><gtr:impact>This panel of MND research experts, along with Association trustees, discussed research applications in detail. They then decided whether the research is good enough to be funded by the Association and fit within our research strategy.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Conference on Frontotemporal Dementias (Manchester)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2C117135-4F78-44ED-A8E3-7D45FBBAD7FD</gtr:id><gtr:impact>Presented paper on C9ORF72.

Clinicians and researchers exchanged knowledge about the latest developments in FTD.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>paper presentation</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Conference, MA Healthcare (London) 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>42D7033A-7DAD-41CB-97C3-5ABFB657B202</gtr:id><gtr:impact>Prof Morris presented a talk at the MA Healthcare Parkinson's conference. Audiences had the opportunity to learn about distinguishing the different Parkinsonisms, update their knowledge on treatments and therapies including exercise and deep brain stimulation, explore the potential for novel treatments in Parkinson's, hear a first-hand carer experience of Parkinson's management strategies, and share and exchange ideas with the leading practitioners in the field.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mahealthcareevents.co.uk/public/MAH%20Parkinsons_2016_4pp%20WEB2.pdf</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MA Healthcare Parkinson's 2015 conference (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9A0DBE6B-C2C1-4AB0-850A-497E1F7F9AC0</gtr:id><gtr:impact>The conference, organised by MA Healthcare in collaboration with the British Journal of Hospital Medicine and the British Journal of Neuroscience Nursing, was attended by a variety of health and social care professionals involved in the management of Parkinson's, including: neurologists, geriatricians, psychiatrists, neurosurgeons, GPs, community mental health teams, nurse specialists, allied health professionals, and trainees. Attendees benefited from presentation and discussion from leading practitioners and researchers, covering topics such as:
- Distinguishing different Parkinsonisms (talk presented by Prof Morris)
- Pre-diagnostic markers of Parkinson's
- Hospitalisation in Parkinson's
- Advances in PET imaging
- Practical strategies for Parkinson's management
- Pharmacological management
- Exercise
- Surgery and Deep Brain Stimulation
- Depression and anxiety
- Palliative care</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Royal Society of Medicine: Genetics of Movement Disorders (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E1A2BFFF-5F08-4ED3-9531-4DC10E7D65D5</gtr:id><gtr:impact>The aim of the meeting was to explain the importance and relevance of medical genetics in the management of patient with movement disorders and to enable the recognition of &amp;quot;common&amp;quot; movement disorders by non-movement disorder specialists. Participants learnt to recognise &amp;quot;common&amp;quot; movement disorders, such as tremor, chorea and ataxia and understood the relevance of medical genetics in the aetiopathogenesis of a variety of disorders associated with abnormal movement. Participants were taught to recognise clinical features, symptoms and signs suggesting a genetic cause for patients with movement disorders, and how to distinguish these from other potential causes. Participants learnt to understand the utility, advantages but also potential difficulties of genetic testing in patients with movement disorders.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queen Square Parkinson's disease and movement disorders course (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A7964606-6147-4161-8869-D20407BAAA9B</gtr:id><gtr:impact>Members of the research team attended the course 'Genetics and cellular mechanisms of Parkinson's disease and Movement Disorders' held at Queen Square. Topics included: current genetics research, bioinformatic analysis, pathological cases, and treatments.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of Society of Physicians in Wales (Port Meirion, Wales)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>535440FF-8497-4467-99BC-A57E3E8EA2BC</gtr:id><gtr:impact>Invited speaker, presented a talk 'Neurogenetics in Gwent - Chromosome 9 linked ALS'.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementia Research Institute meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>712A3E6F-6D32-484A-87C5-2C65757FF7C6</gtr:id><gtr:impact>Meeting to prepare the Dementia Research Institute bid. This was later successfully granted to UCL. The DRI will assemble the necessary critical mass of world-leading researchers and provide access to cutting edge tools and capabilities in order to:

Accelerate the pace of discovery research to identify new targets for drug development
Develop new approaches for delivering effective clinical trials to targeted patient groups
Attract new partnerships with the biopharmaceutical sector to develop new therapeutics and diagnostics and
Develop and promote strategies for interventions that prevent the development or progression of dementia
Provide new insights and technology-based approaches to delivering more effective care and support to people with dementia and their carers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.mrc.ac.uk/about/institutes-units-centres/uk-dementia-research-institute/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School vist, Henry VIII School, Abergavenny</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>8EB208A3-3F48-4E67-9676-3746291C09A3</gtr:id><gtr:impact>Neuroscience day for 6th formers. Viewing of Oliver Sacks's film the Awakenings/ talk/discussion

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ICOSA Meeting - ALS/FTD</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>62B7D8D4-F336-4BCE-95CD-AE18C476C88D</gtr:id><gtr:impact>Invited speaker at meeting on Chromosome 9

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk for Frontotemporal Dementia (FTD) UK meeting 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7E16A9D6-749F-4AFD-925B-C3573043A0A8</gtr:id><gtr:impact>The day presented exciting updates about current and future research for both frontotemporal dementia (FTD) and overlapping conditions such as progressive supranuclear palsy (PSP) and motor neuron disease (MND). Talks covered: brain imaging techniques, genetics, cell function, drug trials and clinical practice.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.ftdtalk.org/ftd-uk-2016-latest-ftd-research-across-uk/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Disease Society Meetings</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>45C6D1E7-3A0A-4438-A02F-DEFAC0636568</gtr:id><gtr:impact>I meet with PDS group members at PDS meetings and provide updates on our research in PD. This includes local (Newport, Bridgend, Bristol, Camarthen, Bronllys) and national (Stratford 2009 - Younger Parkinson's Network Meeting) meetings

We continue to develop an ongoing relationship with the Parkinson's disease society which leads to further referrals (include volunteer patients) for our research</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>ABN Movement Disorders Special Interest Group (ABN MD SIG) meeting (Cambridge)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B75172AA-27CD-4CB7-90F9-870ADADA3018</gtr:id><gtr:impact>The inaugural ABN Movement Disorders Special Interest Group (ABN MD SIG) meeting took place on the 15th and 16th of January 2015 at Downing College, Cambridge. The programme was organised by Professor David Burn (Newcastle) and Dr Paul Worth (Cambridge) and included several internationally renowned speakers. The morning session aimed to summarise current topics that have furthered our understanding in the pathophysiology of movement disorders. The event including discussion on topics such as GBA mutations, the role of alpha-synuclein, novel MRI techniques, recent developments in gene sequencing technologies, neuroprotection studies and case presentations undertaken by Prof Huw Morris.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.acnr.co.uk/2015/06/abn-md-sig-conference/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists Council meeting 2016 (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>82C3692E-8A50-4461-942A-589992C45DC2</gtr:id><gtr:impact>Prof Morris attended the ABN Council meeting, which included lay trustees and council members.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists annual meeting 2016 (Brighton)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>02F5183D-1B7E-49AB-9760-488B208AC4F7</gtr:id><gtr:impact>Members of the research team attended the conference and presented posters to clinicians, researchers and trainees.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.theabn.org/events/forthcoming/abn-annual-meeting-2016.html</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview with BBC News</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D29DDB47-800A-45BD-A69D-55C10EE8E2C0</gtr:id><gtr:impact>http://www.bbc.co.uk/news/uk-wales-south-east-wales-15005209

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interview for Women and Home article: Parkinson's Happens to Young People Too</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>608AB554-D2CD-4CF8-B09F-D5328F906A58</gtr:id><gtr:impact>Gave an interview for Women and Home for the article 'Parkinson's Happens To Young People Too', published 10 March 2015. The article covered important issues for early onset Parkinson's, such as diagnosis, causes and symptoms.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MDS-ES Strategic Planning Retreat (Lisbon)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>26B034C3-20A8-48A1-B4A5-FC4D6C28308C</gtr:id><gtr:impact>Strategic planning meeting organised by the Movement Disorder Society (European section) held in Lisbon, January 2016</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Barnet Parkinson's patient group meeting (Barnet)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C7F734D7-D84D-4548-B0CE-C96452EB3047</gtr:id><gtr:impact>Attended a patient group meeting for Parkinson's patients in the Barnet area. This generated interest in research studies and several patients made contact with the research team to express their interest in being involved in current research studies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Parkinson's UK Research conference: the Parkinson's Families Project</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>012DEC05-82A8-4885-96F2-EE30C83AF2FC</gtr:id><gtr:impact>Our research assistant presented a poster at the Parkinson's UK Research Conference 2016, presenting baseline data from the Parkinson's Families Project.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Movement Disorders Congress 2016 (Berlin)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>39EC7344-4034-4A6D-B97C-AB3939A3B31D</gtr:id><gtr:impact>Members of the research team attended the Movement Disorders Congress in Berlin and presented posters to communicate research findings.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.mdscongress2016.org/Congress-2016.htm</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Younger People Living With Dementia organised by UCL</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D783CE68-7DA3-4CCB-A540-3C4166EA20CA</gtr:id><gtr:impact>A joint conference organised by University College London and the Journal of Dementia Care was held in November 2015. The focus of the meeting was joined up working between psychiatry, neurology and clinical genetics to improve diagnosis.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:url>http://www.careinfo.org/young-dementia-2015/</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's Masterclass (Bristol)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E8FFE297-B468-4F46-88F1-B737CABFC9AC</gtr:id><gtr:impact>Invited speaker at Parkinson's Academy Masterclass, a teaching course for consultants and final year SpR's, GPWSI, Associate Specialists and Staff Grade Physicians.

The course advanced attendees' understanding of Parkinson's disease and related movement disorders through taught sessions, worked examples and mentorship.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.parkinsonsacademy.co.uk/</gtr:url><gtr:year>2012,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PD Genetics update for British Movement Disorders Group (BritMODIS) meeting (Birmingham)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>843E2E82-16AF-4282-A75B-F6CFCBDC8D2E</gtr:id><gtr:impact>The meeting was attended by neurologists, geriatricians and PD nurse specialists, which generated good discussion about multidisciplinary working in Parkinson's Disease.

Sharing information among clinicians.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dementias Portfolio Development Group (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E851C580-9B30-4DFC-81BB-7866BB8F17FC</gtr:id><gtr:impact>Participated in the Portfolio Development Group at Parkinson's UK, London.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>International Consortium on SOD and ALS (Liverpool)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>18761768-6B4B-4C6F-9D2C-0A2BC1F9E964</gtr:id><gtr:impact>Invited talk on genetics of MND at International Consortium on SOD and ALS, held at the University of Liverpool.

Shared knowledge to design better-informed experiments to understand the rare, inherited SOD1 form of MND</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Edgware Research day: Parkinson's: Knowledge, Power, Treat. A vision for the future</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>05E847D6-849F-4350-B0D1-D57F466B6CF8</gtr:id><gtr:impact>This research day was targeted towards local patients at Edgware Community Hospital and Central London Community Healthcare NHS Trust. Researchers and patients presented talks on Parkinson's research and patient experiences. Talks were supplemented by panels, networking and Question and Answer sessions.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists Annual Meeting (Harrogate)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>92DA3F1F-713F-4C81-B8AE-98FDFEB81B4A</gtr:id><gtr:impact>Four day meeting organised by the Association of British Neurologists (ABN) that involved workshops, presentations, training, special interest group discussions and poster presentations. Topics included:
- Audit/quality assurance
- Clinical phenomenology
- Diagnostic investigations
- Commissioning neurology services
- Disease pathophysiology
- Therapeutics
- Case presentations</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Driver and Vehicle Licensing Agency Medical Advisory Panel 2016</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B4A84057-BC63-4A7E-8ED0-4B534E498096</gtr:id><gtr:impact>Prof Morris attended the meeting of the Secretary of State for Transport's Honorary Medical Advisory Panel on driving and disorders of the nervous system. Decisions were made and advice was provided regarding driving and licensing regulations related to neurological conditions.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK Brain Bank meeting (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C95CA3D0-C785-47B7-8AEA-C4F7F36EEAF3</gtr:id><gtr:impact>Meeting with Parkinson's UK regarding Brain Banking</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of British Neurologists - fundraising and council</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9543938C-B741-4E91-AEA9-35B0AFC1B8E3</gtr:id><gtr:impact>Fundraising event and council meeting of the Association of British Neurologists</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IPDGC meeting (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>5EBD53CB-64E0-4D5D-8764-17CF11324DEC</gtr:id><gtr:impact>Organised and hosted a successful meeting with members of the International Parkinson's Disease Genetics Consortium. Members presented and discussed topics including:
- Clinical data and potential collaboration
- Genotype/phenotype data on progression and head injury
- Data collection - HPO, Genomics England and CDE
- Studies in at-risk cohorts
- Potential research questions, such as progression, age of onset analysis, progression to dementia, familial analysis, pathologically confirmed cases, pathology as a quantitative trait, tremor vs. non-tremor dominant cases, and genotyping in prospective cohorts
- Possible actions</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio interview reviewing Michael J Fox's book 'Lucky Man'</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>3A023110-F91C-4716-A6D1-290C7743DA46</gtr:id><gtr:impact>Radio interview on Practical Neurology with Phil Smith. Discussed early-onset Parkinson's, impact of diagnosis and reception of Michael J Fox's memoir.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Short Course Queen Square - PSP</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C4E18D43-44AB-40B0-89E6-E171B19E4242</gtr:id><gtr:impact>Lecture to health professsionals on short course

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CBD Solutions Scientific Meeting (London)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>1E532DDF-0124-4863-889D-CDD01A34AE4B</gtr:id><gtr:impact>The meeting, organised by CBD Solutions, was attended by neurologists and academics and included discussion on:
- Mechanisms of CBD (pathology, genetics, GWAS/tau)
- Models of CBD
- Biomarkers of CBD and cohorts
- Clinic assessments</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Genome Campus Molecular Neurodegeneration course</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>350DC091-266E-4D12-842B-BA90A3CBC48E</gtr:id><gtr:impact>This course provided an overview of the molecular basis of neurodegeneration and the development of treatment strategies to combat neurodegenerative disorders. The programme focused on several disorders including Alzheimer's disease, Parkinson's disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes. Participants gained an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies. The programme was aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchers.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://coursesandconferences.wellcomegenomecampus.org/events/item.aspx?e=606</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MNDA Patient Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>76ADA481-F101-445E-93DE-6C67CB626FCE</gtr:id><gtr:impact>Lecture at MNDA patient meeting

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of the DVLA Honorary Medical Advisory Panel on Driving and Disorders of the Nervous System (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>8DFF699E-77E6-4ABC-BC25-AC23EDD85ACC</gtr:id><gtr:impact>Members of the Honorary Medical Advisory Panel for the DVLA met and discussed:
- Extended period licensing
- Sleep apnoea and impacts
- Regulations regarding isolated seizures
- Visual inattention
- Sudden and disabling events following head injury</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Departmental Seminar Series at Addenbrooke's Hosital (Cambridge)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E79A2A75-182C-4840-8966-C172B8C81E0C</gtr:id><gtr:impact>Invited speaker at Departmental Seminar Series at Addenbrooke's Hospital. Delivered presentation on early onset Parkinson's disease.

Educating and sharing information among health professionals.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar on early onset PD at the Walton Centre (Liverpool)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DD7935E8-DB8F-4335-B603-A0E2A7AC961E</gtr:id><gtr:impact>Invited talk on early onset Parkinson's Disease as part of the departmental seminar series.

Share information</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IPDGC meeting (Paris)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>79D2E1D6-A666-4C4F-B4ED-C0C1B9A4D643</gtr:id><gtr:impact>Meeting of members in the International Parkinson's Disease Genetics Consortium in Paris.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Wellcome Trust advanced course in Molecular Neurology</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C0F7BD8D-94FB-4DE5-A672-E1CAE36E462B</gtr:id><gtr:impact>Invited speaker to Wellcome Trust Advanced course in Molecular Neurology

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BGS - ALS  -Neurodem Cymru</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D79F2C3D-2D8A-4CCC-A510-D08080AAAD41</gtr:id><gtr:impact>Invited speaker on Chromosome 9 to NEURODEM Cymru event

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cardiff Neuroscience meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9C207195-120A-476A-9801-324F5422A579</gtr:id><gtr:impact>Delivered presentation at Cardiff University Neuroscience meeting</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dendron UK PD Clinical Studies Group</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CD84FAB3-3FF4-4D3B-ABF4-50243017013D</gtr:id><gtr:impact>Chair of expert group - developing new research in PD

unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MSA Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>28EC940D-5D8A-455E-B423-AB0D9129E399</gtr:id><gtr:impact>Lecture in MSA Workshop

Led to developing MSA network UK</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting with CBD Solutions 2016 (London)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>391E47A9-DAA0-42CF-8BE4-58C2ED89A4C5</gtr:id><gtr:impact>Meeting with Cortico Basal Degeneration Solutions in London to plan future activities and present current research progress.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Third sector organisations</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Positive Steps in Parkinson's</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4B5142C3-2773-477B-B03E-D17AC31F0660</gtr:id><gtr:impact>The purpose of the meeting was to share practical skills that will enable physicians and nurses to deliver the best care for Parkinson's patients. Along with some of the top Parkinson's experts, the group discussed the latest research and techniques, shared best practice and debated interesting case studies.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.parkinsonsps.com/home</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on early-onset Parkinson's Disease genetics at UK GTN meeting (London)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81C99C16-DABE-469D-8DF5-317405157C29</gtr:id><gtr:impact>65 participants attended the conference, including consultant neurologists, specialist registrars in neurology and interested general paediatricians.

Through the lectures and discussions, it was highlighted that:
? The efficiency of genetic testing could be increased if there was a shift from serial genetic testing to genetic panel testing and potentially in the future to exome-sequencing. 
? There was considerable evidence presented that for conditions which had treatment options available, early genetic testing assisted in the early
intervention and management of the condition with better clinical outcomes. However, there remain a significant number of conditions for which a treatment is not available despite access to genetic tests for diagnosis. Nevertheless, often, early diagnosis of a neurological condition through
genetic testing, using the UKGTN testing criteria, may facilitate management interventions such as accurate genetic counselling. 
? Additional benefits of genetic testing include early and accurate diagnosis, planning of appropriate clinical care, and advice on prognosis. 
? Certain challenges need to be considered in using genetic testing for neurological conditions including access, cost limitations and incidental findings. It is apparent that with discoveries of new genetic contributions to clinical conditions, new clinical pathways and genetic tests will need to be developed. The details of these in turn will need to be disseminated to relevant clinical specialists in a timely manner.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>&quot;Y Move&quot; talk (Leeds)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>B5826048-7940-4C54-941E-52D25FC9631F</gtr:id><gtr:impact>Presented talk at &amp;quot;Y Move&amp;quot; in Leeds.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UCL- DZNE- ICM meeting (Paris)</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>B8251F95-DB3A-46DC-8C45-051CF3B344EB</gtr:id><gtr:impact>Attended a collaborative meeting between Institute du Cerveau et de la Moelle epiniere (ICM), Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZM) and University College London (UCL). Attendees discussed:
- Translational models of PD
- Neurophysiology, neuropsychology, motor and non-motor symptoms in PD
- Biomarkers, multimodal, methodology of PD
- Brain imaging in PD
- Neuropathology and mechanisms of neurodegeneration in PD
- Genetics and molecular aspects of PD
- Therapeutic trials in PD</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Seminar on Corticobasal degeneration - from molecular mechanisms to potential treatment (Stockholm)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FA56683D-BC4E-48D6-A8C1-CE7A3AC0A8A8</gtr:id><gtr:impact>Invited speaker at seminar titled 'Corticobasal degeneration - from molecular mechanisms to potential treatment', organised by Karolinska Institutet Seminars, CBD Solutions.

Sharing information among researchers</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Annual meeting of the Association of British Neurologists (Cambridge)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87F1E88A-8BF5-434E-A859-0ABAEAC72DE2</gtr:id><gtr:impact>Invited talk on current genetic approaches to diagnosis, and emerging faster and less expensive methods of genomic analysis. 615 delegates, including medical students, junior doctors and non-physicians, attended lectures and teaching sessions.

Audience generated positive feedback and reported being stimulated in their knowledge of neurology and genetics.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>IBRO-ARC Egypt Neuroscience School (Cairo)</gtr:description><gtr:form>Scientific meeting (conference/symposium etc.)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>3E694893-E93D-4022-AE8D-48A62A530D2E</gtr:id><gtr:impact>Invited talk on the genetics of Parkinson's Disease and diagnosis of movement disorders at IBRO-ARC Egypt Neuroscience School on &amp;quot;Epigenetics and neurological disorders: from bench side to bedside (PD in Focus)&amp;quot;.

Unknown</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BritMODIS 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C2FD40AD-F183-4DC3-B66F-1A3D8C0B4949</gtr:id><gtr:impact>The meeting provided a forum for education in movement disorders and was organized by the British Geriatrics Society Movement Disorders Section, Association of British Neurologists Movement Disorders Special Interest Group, Parkinson's Disease Nurse Specialist Association and Parkinson's UK. The meeting highlighted current clinical practice and provided a platform to present research outcomes and showcase successful service delivery. 

This event was organized for healthcare professionals working in the field of movement disorders. The day provided a forum for scientific discussion and clinical updates and enables a multidisciplinary audience of healthcare professionals to share their experiences of best clinical practice.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>https://www.eiseverywhere.com/ehome/152739</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Functional pathway and gene ontology analysis of whole genome data in Parkinsons disease</gtr:description><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>665A1C70-9C0B-4CC4-99F7-5CAF45DD13BF</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>294808</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A Longitudinal Clinical and Biomarker Study of Progressive Supranuclear Palsy and Cortico-Basal Syndrome</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>40D59DB0-5A36-45A6-B2EB-DDF4530A7FD1</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The role of common DNA variants in Parkinson's disease (Wellcome Trust Case Control Consortium 2)</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>27635B98-C424-454A-ABA1-F7C0CE2EDBD0</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228208</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sara Koe Research Fellowship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>32665BDA-D05E-4EA3-9194-072A4EABDD81</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>305000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Registry and Longitudinal Study of Cortico-Basal Syndrome</gtr:description><gtr:end>2016-11-02</gtr:end><gtr:fundingOrg>CBD Solutions</gtr:fundingOrg><gtr:id>B987A5A1-6997-4830-8FEE-FBE849ACEE0A</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Institutional Strategic Support Fund</gtr:department><gtr:description>Royal Free Parkinson's PPI Research Group</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>EBAD5780-CF72-4171-B7E0-091E9C55B147</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>38168</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Clinical Research Network North Thames: - Research Capability Funding - PFP Research Assistant post (&amp;pound;38168; 2016 - 2017)</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>NIHR CLAHRC North Thames</gtr:fundingOrg><gtr:id>08E5AC12-A3B5-4889-91F2-7CF8F9F9256C</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Parkinson's repository of bio samples and network datasets: PRoBaND</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>EA092361-048F-48BB-A904-E053252CB1CA</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Filling the genetic gaps-exome sequencing in Parkinson's disease (co-applicant)</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>EF0BBFB7-54FD-4B0A-AFAC-26ADEABBC438</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clinical and pathological study of chronic traumatic encephalopathy in retired professional soccer players</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>E2FDE557-8C41-4813-ABB8-4388D0717894</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1498</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Institutional Strategic Support Fund</gtr:department><gtr:description>A participant's guide to user- friendly information in genetic research</gtr:description><gtr:end>2015-06-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>C69A922F-E7DD-4E7A-9858-05885D267180</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>184697</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of CSF biobank and CSF biomarkers for PSP</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>DCB7D69C-19A0-4A0D-B267-F2EC73D79E20</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>39652</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Capability Funding - PSP Study Coordinator post</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>NIHR Clinical Research Network North Thames</gtr:fundingOrg><gtr:id>D8F93445-A8C3-4713-BDC2-ECEE87E5BC44</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28162</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRN Research Capability Funding - PFP Research Assistant post</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>NIHR Clinical Research Network North Thames</gtr:fundingOrg><gtr:id>194BE7B4-9F97-458E-9E28-357CBE469AE0</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Create a nested CPT resource with the CANDAS biobank using the CANDAS consent to store genetic data from PD-STAT</gtr:description><gtr:fundingOrg>Cure Parkinson's Trust</gtr:fundingOrg><gtr:id>1591307D-2FC8-4068-B699-FE529B7DF534</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>515338</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Defining the genetic aetiology of early onset Parkinson's disease</gtr:description><gtr:end>2014-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>1F798398-9F72-4C3E-83A4-7A68CEB987FB</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>48972</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Parkinson's Families Pilot Project - Genomics England Study</gtr:description><gtr:end>2017-01-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:fundingRef>K-1501</gtr:fundingRef><gtr:id>6A89945A-E80B-4B2B-91AB-926F684CCCCD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>A Longitudinal Biomarker Study of Sports Related Head Injury and Outcomes</gtr:description><gtr:end>2018-05-02</gtr:end><gtr:fundingOrg>The Drake Foundation</gtr:fundingOrg><gtr:id>5CB03133-D789-4635-BFAD-6559DDE92693</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>184000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Autophagic dysfunction in cellular models of inherited MND/FTLD (co-applicant)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>A02F4630-575C-42CF-8B79-3DF7C4133F60</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>270000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Clincial and genetic investigation of th epsilon-sarcoglycan (SGCE) comples in neurologic and psychiatric disease</gtr:description><gtr:end>2014-08-02</gtr:end><gtr:fundingOrg>Welsh Clinical Academic Training (WCAT)</gtr:fundingOrg><gtr:id>F7B3DE36-F3C6-4C76-A967-2B2755127639</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Ipsen Fund</gtr:department><gtr:description>Clinical and genetic investigation of the epsilon-sarcoglycan (SGCE) complex in neurologic and psychiatric disease/Ipsen Ltd</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Ipsen</gtr:fundingOrg><gtr:id>C4ADB7F1-8B7A-4802-8720-3F4B81D0DC67</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>53000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Follow-up of Genome-wide association studies in large cohorts of Parkinson's Disease</gtr:description><gtr:end>2011-02-02</gtr:end><gtr:fundingOrg>Parkinson's UK (Parkinson's Disease Society)</gtr:fundingOrg><gtr:id>9DAB353C-5B6D-4940-BD30-19220960AA16</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228396</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Identification of the gene for Motor Neurone Disease and fronto-temporal demential linked to chromosome 9/Motor Neurone Disease Association</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Motor Neurone Disease Association (MND)</gtr:fundingOrg><gtr:id>22606975-FC0E-4395-8300-27A286ECDA2C</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>35000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Strategic Biomarkers Initiative Project</gtr:description><gtr:end>2016-03-02</gtr:end><gtr:fundingOrg>NIHR BRC Biomedical Research Centre</gtr:fundingOrg><gtr:id>F08D420C-F9D8-4FA4-B1A5-606B6A1E8738</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>H. R. M is a co-applicant on a patent application related to C9ORF72 - Method for diagnosing a neurodegenerative disease (PCT/GB2012/052140). 

1 in 50,000 people have motor neuron disease (MND). Amyotrophic lateral sclerosis (ALS) is a form of MND characterized by the death of motor neurons in the brain, brainstem and spinal cord. This leads to wasting in the limbs and progressive paralysis, and there are no effective therapies - it is fatal due to eventual respiratory failure, typically two to three years after the onset of symptoms. Around 5% of ALS cases are familial (inherited). Frontotemporal dementia (FTD) is a relatively common cause of dementia in younger patients but is overall less common than Alzheimer disease or Cortical Lewy body disease. Symptoms vary but can include behavioural and personality changes, problems with language skills and inability to plan or organize complex tasks. There is evidence to suggest that there is an overlap with these ALS and FTD as symptoms of both conditions can occur in the same patient, in the same families and as alternative presentations of pathogenic C9ORF72 (OMIM 614260) mutations.</gtr:description><gtr:id>D2407454-BB69-4057-AD04-5A9EBB0B6499</gtr:id><gtr:impact>The recent discovery of large 6bp repeat expansions in chromosome 9 open reading frame 72 (C9ORF72 - chromosome location 9p21) is diagnostic of familial ALS and FTD, and may also be used as a predictive test for at-risk familial members [Ref. Neuron 2011, 72(2); 257-68]. Mutations in MAPT, GRN, TARDP and UBQLN2 genes, among others, may cause similar clinical syndromes.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:patentId>PCT/GB2012/052140</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>C9PORF72: Method for Diagnosing a Neurodegenerative Disease</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NIHR Clinical Research Network North Thames Specialty Lead</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>462927C9-C63D-4464-ABD2-48801AFB0452</gtr:id><gtr:impact>As the NIHR CRN specialty lead for Neurodegeneration, Prof Huw Morris is involved in influencing research decisions and activity.</gtr:impact><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Honorary Medical Advisor with expertise in Parkinson's disease for Secretary of State for Transport's Panel on Driving and Disorders of the Nervous System (DVLA)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C4AD10E2-E7B3-48F1-AB59-1BF5A653B4EC</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Driver and Vehicle Licensing Agency Medical Advisory Panel 2016</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>BAF1C502-F6E7-4EB0-BDC3-1EAABC802888</gtr:id><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>This is a within-subject, controlled open-label study seeking to determine if EPI-589 can alter the biochemical signature of PD as assessed by peripheral blood and brain imaging biomarkers. Data will also be collected on disease-relevant clinical measures will be collected. This project is sponsored and funded by Edison Pharmaceuticals.</gtr:description><gtr:id>2EDB080C-63B8-4131-9E80-1C749D4DDE30</gtr:id><gtr:impact>The safety trial is still ongoing.</gtr:impact><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Safety and Biomarker Study of EPI-589 in Parkinson's Disease</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:url>http://www.hra.nhs.uk/news/research-summaries/safety-and-biomarker-study-with-epi-589-in-parkinsons-disease/</gtr:url><gtr:yearDevCompleted>2017</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>http://www.wales.nhs.uk/sites3/documents/525/MI-MGN-ALS-FTD_21.pdf</gtr:description><gtr:id>82C8812F-DA31-4E01-B048-CAE51FBC9D40</gtr:id><gtr:impact>unknown</gtr:impact><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>C9orf72</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.wales.nhs.uk/sites3/documents/525/MI-MGN-ALS-FTD_21.pdf</gtr:url><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Genie is an online database that manages recruitment, data collection and submission to Genomics England</gtr:description><gtr:id>0A810EE2-9636-4FAD-8415-AF904C22A683</gtr:id><gtr:impact>Ease of data collection and search</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Genie Genomics England database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Research Electronic Data Capture (REDCap) is a secure web application for building and managing online surveys and databases. Databases have been set up for current projects in the research team, including the Parkinson's Families Project, PROSPECT and the European Registry of CBD. These databases allow for data entry by both researchers and participants around the UK online through a secure web connection, and could facilitate easy data sharing in the future to collaborators. The databases hold large amounts of clinical and phenotypic data from research participants.</gtr:description><gtr:id>1EBA398B-AE1D-474C-A6B9-38F13F39570F</gtr:id><gtr:impact>None as yet.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>REDCap databases</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://project-redcap.org/</gtr:url></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>Records of patient details, consultant details, clinical summary and family history</gtr:description><gtr:id>4C475A4C-4B2C-4448-BB6F-00CFD3E57A8C</gtr:id><gtr:impact>Enables researchers to store important patient details for large numbers of study participants</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CANDAS/WPG database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Collection of DNA samples and Peripheral Blood Lymphocytes for PD patients</gtr:description><gtr:id>F92850FA-3868-467E-AD3C-1B3B67377AD4</gtr:id><gtr:impact>Use in gene mapping studies</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Parkinson's disease - biological collection</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E78AAF3E-A988-411C-AEB4-A539180C42E8"><gtr:id>E78AAF3E-A988-411C-AEB4-A539180C42E8</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/10AC4096-67A9-428A-BB5C-8A892D33D86B"><gtr:id>10AC4096-67A9-428A-BB5C-8A892D33D86B</gtr:id><gtr:title>The motor phenotype of Parkinson's disease in relation to age at onset.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be6ea1c232be937c5290da4b55716e40"><gtr:id>be6ea1c232be937c5290da4b55716e40</gtr:id><gtr:otherNames>Wickremaratchi MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0EA2D7DF-D75C-4B16-8664-80E6DDE1A04E"><gtr:id>0EA2D7DF-D75C-4B16-8664-80E6DDE1A04E</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F8F29A3B-7EC5-4867-BEA6-B63DC51CD18D"><gtr:id>F8F29A3B-7EC5-4867-BEA6-B63DC51CD18D</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A878497-0820-476C-8653-29B1B8CEF04F"><gtr:id>6A878497-0820-476C-8653-29B1B8CEF04F</gtr:id><gtr:title>Hyposmia in progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7FC015AA-2AC3-4499-A630-390A2B8ADBD7"><gtr:id>7FC015AA-2AC3-4499-A630-390A2B8ADBD7</gtr:id><gtr:title>Recent advances in Parkinson's disease genetics.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cfdbbd778d82415d550b65bbacb4f286"><gtr:id>cfdbbd778d82415d550b65bbacb4f286</gtr:id><gtr:otherNames>Lubbe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4D8EAA80-C505-4C71-B5FB-FD0F8DB0F29E"><gtr:id>4D8EAA80-C505-4C71-B5FB-FD0F8DB0F29E</gtr:id><gtr:title>Visual dysfunction in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a122567e3854ed708543b4c753c9fc8e"><gtr:id>a122567e3854ed708543b4c753c9fc8e</gtr:id><gtr:otherNames>Weil RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EBBA3978-3862-48D9-851B-573C47FBFF64"><gtr:id>EBBA3978-3862-48D9-851B-573C47FBFF64</gtr:id><gtr:title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e2d0f395414b93ca8e16b698d9d8d12"><gtr:id>1e2d0f395414b93ca8e16b698d9d8d12</gtr:id><gtr:otherNames>International Parkinson Disease Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CBAAD168-A7C3-42B9-BBA5-199C2AC43B2C"><gtr:id>CBAAD168-A7C3-42B9-BBA5-199C2AC43B2C</gtr:id><gtr:title>NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CD7462A-D192-4EA4-BAD4-57BFA7719D56"><gtr:id>5CD7462A-D192-4EA4-BAD4-57BFA7719D56</gtr:id><gtr:title>Perry syndrome due to the DCTN1 G71R mutation: a distinctive levodopa responsive disorder with behavioral syndrome, vertical gaze palsy, and respiratory failure.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/64310f53e10544c3a3597aeeb44ffb1f"><gtr:id>64310f53e10544c3a3597aeeb44ffb1f</gtr:id><gtr:otherNames>Newsway V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D94B7426-0732-46B6-B387-56101895C1D0"><gtr:id>D94B7426-0732-46B6-B387-56101895C1D0</gtr:id><gtr:title>A novel presenilin 1 mutation, I202F occurring at a previously predicted pathogenic site causing autosomal dominant Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27e493ec871fb8354d99a5bce47210df"><gtr:id>27e493ec871fb8354d99a5bce47210df</gtr:id><gtr:otherNames>Church A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EDE61CD-A83A-4300-948B-9383D61831D3"><gtr:id>9EDE61CD-A83A-4300-948B-9383D61831D3</gtr:id><gtr:title>Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/73f2f0764dd1bcc79b805b94497f0c43"><gtr:id>73f2f0764dd1bcc79b805b94497f0c43</gtr:id><gtr:otherNames>Sim?n-S?nchez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/614AF6EC-ED24-4BB0-A78A-5FF991D4C2F6"><gtr:id>614AF6EC-ED24-4BB0-A78A-5FF991D4C2F6</gtr:id><gtr:title>Parkinson's disease in GTP cyclohydrolase 1 mutation carriers.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6FDBB592-5E85-4FB5-AD08-E6D4DDF01432"><gtr:id>6FDBB592-5E85-4FB5-AD08-E6D4DDF01432</gtr:id><gtr:title>Polygenic risk of Parkinson disease is correlated with disease age at onset.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/68B467A1-E60A-4C6D-BEF1-852E19C20E9B"><gtr:id>68B467A1-E60A-4C6D-BEF1-852E19C20E9B</gtr:id><gtr:title>Client and therapist views on exercise programmes for early-mid stage Parkinson's disease and Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Disability and rehabilitation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/836ab228d0a2d9cab611cd19460e2edc"><gtr:id>836ab228d0a2d9cab611cd19460e2edc</gtr:id><gtr:otherNames>Quinn L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0963-8288</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F4CB8C82-7202-48FF-ABBC-FD66A721A91B"><gtr:id>F4CB8C82-7202-48FF-ABBC-FD66A721A91B</gtr:id><gtr:title>Polygenic risk of Parkinson disease is correlated with disease age at onset.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/dfb50ad82a115894d592e09569cffa3f"><gtr:id>dfb50ad82a115894d592e09569cffa3f</gtr:id><gtr:otherNames>Escott-Price V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/762DA23D-140E-4FF7-8C45-C44376EF0733"><gtr:id>762DA23D-140E-4FF7-8C45-C44376EF0733</gtr:id><gtr:title>SGCZ mutations are unlikely to be associated with myoclonus dystonia.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E0E45245-2341-40B3-AD6E-9DDF573DD8BD"><gtr:id>E0E45245-2341-40B3-AD6E-9DDF573DD8BD</gtr:id><gtr:title>Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.</gtr:title><gtr:parentPublicationTitle>Journal of Parkinson's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a13d851deef459249d6e218a93ec16eb"><gtr:id>a13d851deef459249d6e218a93ec16eb</gtr:id><gtr:otherNames>Swallow DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1877-7171</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/57AB2E54-316C-4D97-9CFE-E3190CE1F840"><gtr:id>57AB2E54-316C-4D97-9CFE-E3190CE1F840</gtr:id><gtr:title>C9ORF72 expansion in amyotrophic lateral sclerosis/frontotemporal dementia also causes parkinsonism.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cff10bee5d72bc02ba737264f5aea808"><gtr:id>cff10bee5d72bc02ba737264f5aea808</gtr:id><gtr:otherNames>O'Dowd S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39CDF1B3-2512-48CB-86BB-4AA7E2029AE5"><gtr:id>39CDF1B3-2512-48CB-86BB-4AA7E2029AE5</gtr:id><gtr:title>Two-stage association study and meta-analysis of mitochondrial DNA variants in Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65eb931f142b9d0a96c1e2e4b5b1f6a7"><gtr:id>65eb931f142b9d0a96c1e2e4b5b1f6a7</gtr:id><gtr:otherNames>Hudson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A7D32D7C-0ABC-4BE2-BC6D-B9E8FE1B197B"><gtr:id>A7D32D7C-0ABC-4BE2-BC6D-B9E8FE1B197B</gtr:id><gtr:title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/405062aea31e15048134bff16a4a7b11"><gtr:id>405062aea31e15048134bff16a4a7b11</gtr:id><gtr:otherNames>Renton AE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B264E26A-E3DB-4104-8DCD-786D4524721A"><gtr:id>B264E26A-E3DB-4104-8DCD-786D4524721A</gtr:id><gtr:title>Analysis of genome-wide association studies of Alzheimer disease and of Parkinson disease to determine if these 2 diseases share a common genetic risk.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d14c3a9646f0da9792d2b4276c13d04a"><gtr:id>d14c3a9646f0da9792d2b4276c13d04a</gtr:id><gtr:otherNames>Moskvina V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8B87F73D-E0BB-449A-940D-A2E3AEDBE4CE"><gtr:id>8B87F73D-E0BB-449A-940D-A2E3AEDBE4CE</gtr:id><gtr:title>CHCHD2 and Parkinson's disease</gtr:title><gtr:parentPublicationTitle>The Lancet Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2799c24a29f08ff3d5a71022d279d8b8"><gtr:id>2799c24a29f08ff3d5a71022d279d8b8</gtr:id><gtr:otherNames>Jansen I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/904BC6F6-2FD9-4767-BAB0-6D42509B51B8"><gtr:id>904BC6F6-2FD9-4767-BAB0-6D42509B51B8</gtr:id><gtr:title>Parkinson's disease: chameleons and mimics.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/943f72cd687d86f716c47043bea277d9"><gtr:id>943f72cd687d86f716c47043bea277d9</gtr:id><gtr:otherNames>Ali K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F7A8C082-1296-412F-91D2-CC28F4165DB4"><gtr:id>F7A8C082-1296-412F-91D2-CC28F4165DB4</gtr:id><gtr:title>Variation in tau isoform expression in different brain regions and disease states.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4261AF62-8324-48A5-BD04-4F85F93BB516"><gtr:id>4261AF62-8324-48A5-BD04-4F85F93BB516</gtr:id><gtr:title>Benign hereditary chorea related to NKX2.1: expansion of the genotypic and phenotypic spectrum.</gtr:title><gtr:parentPublicationTitle>Developmental medicine and child neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0012-1622</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4BB31655-E81F-491F-A6C9-6277E446A307"><gtr:id>4BB31655-E81F-491F-A6C9-6277E446A307</gtr:id><gtr:title>SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/602953AB-3307-4B89-BA20-7521AC91B899"><gtr:id>602953AB-3307-4B89-BA20-7521AC91B899</gtr:id><gtr:title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11f6020b757bd989fc204657e8aabfac"><gtr:id>11f6020b757bd989fc204657e8aabfac</gtr:id><gtr:otherNames>Waite AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0D09ED61-5A02-44A4-A6E0-7360CFC3004A"><gtr:id>0D09ED61-5A02-44A4-A6E0-7360CFC3004A</gtr:id><gtr:title>Is the MC1R variant p.R160W associated with Parkinson's?</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/704428C4-33F4-4D6D-85C6-E7B2CB3EA969"><gtr:id>704428C4-33F4-4D6D-85C6-E7B2CB3EA969</gtr:id><gtr:title>Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1aa7d68da72e3547436051956af0d4cb"><gtr:id>1aa7d68da72e3547436051956af0d4cb</gtr:id><gtr:otherNames>Malek N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4707B35D-31E5-49C1-80B8-F565AA150B83"><gtr:id>4707B35D-31E5-49C1-80B8-F565AA150B83</gtr:id><gtr:title>Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.</gtr:title><gtr:parentPublicationTitle>Molecular neurodegeneration</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8cf5553107e55c233b68c1efaf1db243"><gtr:id>8cf5553107e55c233b68c1efaf1db243</gtr:id><gtr:otherNames>Kiely AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1750-1326</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5AAC4217-64FA-44AC-97AC-8AB7ADEA1A6D"><gtr:id>5AAC4217-64FA-44AC-97AC-8AB7ADEA1A6D</gtr:id><gtr:title>Chromosome 9 ALS and FTD locus is probably derived from a single founder.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb5ecebb0a95326732850cb51e132dc6"><gtr:id>bb5ecebb0a95326732850cb51e132dc6</gtr:id><gtr:otherNames>Mok K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF7DEF34-EEA9-433C-916B-E7AF69B663AD"><gtr:id>BF7DEF34-EEA9-433C-916B-E7AF69B663AD</gtr:id><gtr:title>Parkinson's disease--the debate on the clinical phenomenology, aetiology, pathology and pathogenesis.</gtr:title><gtr:parentPublicationTitle>Journal of Parkinson's disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc3d325cdc9f5b30d594bd43639eab9f"><gtr:id>cc3d325cdc9f5b30d594bd43639eab9f</gtr:id><gtr:otherNames>Jenner P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1877-7171</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3464D38D-EC61-46B0-A8C6-948A36B4AD81"><gtr:id>3464D38D-EC61-46B0-A8C6-948A36B4AD81</gtr:id><gtr:title>Recent advances in the genetics of the ALS-FTLD complex.</gtr:title><gtr:parentPublicationTitle>Current neurology and neuroscience reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65254d84c1c1d793d936a4d8cbfdb0f9"><gtr:id>65254d84c1c1d793d936a4d8cbfdb0f9</gtr:id><gtr:otherNames>Morris HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1528-4042</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B54CB22D-FDDA-4B79-B7D7-9B33EA7C4253"><gtr:id>B54CB22D-FDDA-4B79-B7D7-9B33EA7C4253</gtr:id><gtr:title>Defining neurodegeneration on Guam by targeted genomic sequencing.</gtr:title><gtr:parentPublicationTitle>Annals of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/14f21c098907802100e4488ee4bed78c"><gtr:id>14f21c098907802100e4488ee4bed78c</gtr:id><gtr:otherNames>Steele JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0364-5134</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E723FC5D-56C7-461F-BE7F-338A730F170C"><gtr:id>E723FC5D-56C7-461F-BE7F-338A730F170C</gtr:id><gtr:title>The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d7aa66f560c588319c8b7c3bb0e2a30"><gtr:id>1d7aa66f560c588319c8b7c3bb0e2a30</gtr:id><gtr:otherNames>Wardle M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53D948AF-0BF8-4E23-AB95-DD909E9D0EAD"><gtr:id>53D948AF-0BF8-4E23-AB95-DD909E9D0EAD</gtr:id><gtr:title>Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9d9b30d099d6baedd937038ef4d2f899"><gtr:id>9d9b30d099d6baedd937038ef4d2f899</gtr:id><gtr:otherNames>Beilina A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F149CD06-7F6E-4200-BE36-637BB783070A"><gtr:id>F149CD06-7F6E-4200-BE36-637BB783070A</gtr:id><gtr:title>Clinical and genetic characteristics of non-Asian dentatorubral-pallidoluysian atrophy: A systematic review.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1d7aa66f560c588319c8b7c3bb0e2a30"><gtr:id>1d7aa66f560c588319c8b7c3bb0e2a30</gtr:id><gtr:otherNames>Wardle M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/18CF1720-0EA0-472E-8887-6BBCA0AC3DCD"><gtr:id>18CF1720-0EA0-472E-8887-6BBCA0AC3DCD</gtr:id><gtr:title>Olfaction in Parkin single and compound heterozygotes in a cohort of young onset Parkinson's disease patients.</gtr:title><gtr:parentPublicationTitle>Acta neurologica Scandinavica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1aa7d68da72e3547436051956af0d4cb"><gtr:id>1aa7d68da72e3547436051956af0d4cb</gtr:id><gtr:otherNames>Malek N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0001-6314</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/32F71547-10E2-4D93-9C9C-4B509EC2B98B"><gtr:id>32F71547-10E2-4D93-9C9C-4B509EC2B98B</gtr:id><gtr:title>Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad3f4aad48683e6e281e5a2c104a3d81"><gtr:id>ad3f4aad48683e6e281e5a2c104a3d81</gtr:id><gtr:otherNames>UK Parkinson's Disease Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CBB73739-2B7D-4229-A76B-26AE4AEE0241"><gtr:id>CBB73739-2B7D-4229-A76B-26AE4AEE0241</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5ed587de899b30ad5f3dce3fc99e9d0a"><gtr:id>5ed587de899b30ad5f3dce3fc99e9d0a</gtr:id><gtr:otherNames>Keller MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BAE16B04-AE59-4F81-823E-6E1480729377"><gtr:id>BAE16B04-AE59-4F81-823E-6E1480729377</gtr:id><gtr:title>The frequency of spinocerebellar ataxia type 23 in a UK population.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/41c4d0dfc03600335329f8ac761e66b0"><gtr:id>41c4d0dfc03600335329f8ac761e66b0</gtr:id><gtr:otherNames>Fawcett K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C58F77BE-3AD7-4CA7-8B7F-1BED01090768"><gtr:id>C58F77BE-3AD7-4CA7-8B7F-1BED01090768</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease</gtr:title><gtr:parentPublicationTitle>Human Molecular Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b463e3b0fd8b6a0fbd4f7e43ecff6a2b"><gtr:id>b463e3b0fd8b6a0fbd4f7e43ecff6a2b</gtr:id><gtr:otherNames>Keller M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/940811D6-BAA4-4DEC-B215-055C5F755F22"><gtr:id>940811D6-BAA4-4DEC-B215-055C5F755F22</gtr:id><gtr:title>Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b2f8dfe154301fda0ca7dc5fa167fe8"><gtr:id>9b2f8dfe154301fda0ca7dc5fa167fe8</gtr:id><gtr:otherNames>Ryan NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/78FE6F97-5114-4B0C-B899-446457195987"><gtr:id>78FE6F97-5114-4B0C-B899-446457195987</gtr:id><gtr:title>Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CD7942D0-0AB6-4DD7-8652-AE1448E749EE"><gtr:id>CD7942D0-0AB6-4DD7-8652-AE1448E749EE</gtr:id><gtr:title>Tau acts as an independent genetic risk factor in pathologically proven PD.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/80bdbfdd0b1d93ff7f53295d25d425e7"><gtr:id>80bdbfdd0b1d93ff7f53295d25d425e7</gtr:id><gtr:otherNames>Charlesworth G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3AB5EFEF-AAF5-46FC-8674-140DB7089923"><gtr:id>3AB5EFEF-AAF5-46FC-8674-140DB7089923</gtr:id><gtr:title>The effect of onset age on the clinical features of Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>European journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be6ea1c232be937c5290da4b55716e40"><gtr:id>be6ea1c232be937c5290da4b55716e40</gtr:id><gtr:otherNames>Wickremaratchi MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1351-5101</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8BA25209-04ED-43EA-A92A-81BFE121AF62"><gtr:id>8BA25209-04ED-43EA-A92A-81BFE121AF62</gtr:id><gtr:title>Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cc6be3b3e5ee776d6c6cd87eccb0be6f"><gtr:id>cc6be3b3e5ee776d6c6cd87eccb0be6f</gtr:id><gtr:otherNames>Mok KY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/088F28DF-D175-4121-A0B4-308B56865715"><gtr:id>088F28DF-D175-4121-A0B4-308B56865715</gtr:id><gtr:title>Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6d633de923aea18df03c8589daadc941"><gtr:id>6d633de923aea18df03c8589daadc941</gtr:id><gtr:otherNames>Pichler I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D5E20FED-1C64-4018-BBCB-A3948DF2E61C"><gtr:id>D5E20FED-1C64-4018-BBCB-A3948DF2E61C</gtr:id><gtr:title>Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/294db2869edeb2078cb0efde58ad2c97"><gtr:id>294db2869edeb2078cb0efde58ad2c97</gtr:id><gtr:otherNames>Kilarski LL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BFF497E0-1D70-4C0C-8F8E-34443FC3DAF1"><gtr:id>BFF497E0-1D70-4C0C-8F8E-34443FC3DAF1</gtr:id><gtr:title>Psychiatric disorders, myoclonus dystonia, and the epsilon-sarcoglycan gene: a systematic review.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5D9576C2-6325-47F6-BC54-AB8F18204B43"><gtr:id>5D9576C2-6325-47F6-BC54-AB8F18204B43</gtr:id><gtr:title>SGCE mutations cause psychiatric disorders: clinical and genetic characterization.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/405244B1-D2EC-437D-AFB5-8AEE732F0688"><gtr:id>405244B1-D2EC-437D-AFB5-8AEE732F0688</gtr:id><gtr:title>Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86694d88fb2c9bb553f0bfcfc3584548"><gtr:id>86694d88fb2c9bb553f0bfcfc3584548</gtr:id><gtr:otherNames>Graves TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/81B3B175-CDC3-4C77-863B-B04567E582EB"><gtr:id>81B3B175-CDC3-4C77-863B-B04567E582EB</gtr:id><gtr:title>Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.</gtr:title><gtr:parentPublicationTitle>Clinical neurology and neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/83e57575be4e049931208ea594a82fb1"><gtr:id>83e57575be4e049931208ea594a82fb1</gtr:id><gtr:otherNames>Momeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-8467</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/994AD574-8F69-48C8-9086-FCA82C5FB688"><gtr:id>994AD574-8F69-48C8-9086-FCA82C5FB688</gtr:id><gtr:title>Genetic and phenotypic characterization of complex hereditary spastic paraplegia.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/712E71AA-C2D5-4D69-9132-0580C993BF08"><gtr:id>712E71AA-C2D5-4D69-9132-0580C993BF08</gtr:id><gtr:title>Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d266192c3f1da4e2a8ec1b2347453e58"><gtr:id>d266192c3f1da4e2a8ec1b2347453e58</gtr:id><gtr:otherNames>Lesage S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43661321-6098-446E-9B28-C28D877F8165"><gtr:id>43661321-6098-446E-9B28-C28D877F8165</gtr:id><gtr:title>Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be6ea1c232be937c5290da4b55716e40"><gtr:id>be6ea1c232be937c5290da4b55716e40</gtr:id><gtr:otherNames>Wickremaratchi MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3A8D02E5-3FA7-431E-9555-68AAAEE2D9B1"><gtr:id>3A8D02E5-3FA7-431E-9555-68AAAEE2D9B1</gtr:id><gtr:title>Susceptibility loci for pigmentation and melanoma in relation to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/95c25a60693a992681a42b54c91bff9e"><gtr:id>95c25a60693a992681a42b54c91bff9e</gtr:id><gtr:otherNames>Dong J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A96B1E7-3118-4257-8434-B69398225BAB"><gtr:id>0A96B1E7-3118-4257-8434-B69398225BAB</gtr:id><gtr:title>Distal hereditary motor neuropathy with vocal cord paresis: from difficulty in choral singing to a molecular genetic diagnosis.</gtr:title><gtr:parentPublicationTitle>Practical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/030c914c043620eb7beca9b8bb06a986"><gtr:id>030c914c043620eb7beca9b8bb06a986</gtr:id><gtr:otherNames>Ingram G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1474-7758</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/41138313-C700-4274-95FB-F03826FB7C8C"><gtr:id>41138313-C700-4274-95FB-F03826FB7C8C</gtr:id><gtr:title>Quality of life in young- compared with late-onset Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3f73c6c51893c9685495dea683ff7148"><gtr:id>3f73c6c51893c9685495dea683ff7148</gtr:id><gtr:otherNames>Knipe MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/23B95843-7EDA-4017-9E54-8753B9A90440"><gtr:id>23B95843-7EDA-4017-9E54-8753B9A90440</gtr:id><gtr:title>Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/53FAA1AC-B7D8-4277-918F-564839A2C5FF"><gtr:id>53FAA1AC-B7D8-4277-918F-564839A2C5FF</gtr:id><gtr:title>A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ccc5b5762113644a4bc53ab2a81094d8"><gtr:id>ccc5b5762113644a4bc53ab2a81094d8</gtr:id><gtr:otherNames>Magdalinou NK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/44A16EFA-B7CF-47B8-A5B3-F305456EC803"><gtr:id>44A16EFA-B7CF-47B8-A5B3-F305456EC803</gtr:id><gtr:title>A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ed0f28b35d5e4240d5af6d917b092bf"><gtr:id>8ed0f28b35d5e4240d5af6d917b092bf</gtr:id><gtr:otherNames>Mencacci NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6A770621-B47C-4D43-AF51-8A2CA69D29B5"><gtr:id>6A770621-B47C-4D43-AF51-8A2CA69D29B5</gtr:id><gtr:title>Functional Magnetic Resonance Imaging Neurofeedback-guided Motor Imagery Training and Motor Training for Parkinson's Disease: Randomized Trial.</gtr:title><gtr:parentPublicationTitle>Frontiers in behavioral neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/933ed97a3947b15a32409f83822b1ac4"><gtr:id>933ed97a3947b15a32409f83822b1ac4</gtr:id><gtr:otherNames>Subramanian L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1662-5153</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B28891C8-5B1B-4486-B814-C374E2DF0012"><gtr:id>B28891C8-5B1B-4486-B814-C374E2DF0012</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BF64742C-3A8A-4614-BEC6-7F719E5865D4"><gtr:id>BF64742C-3A8A-4614-BEC6-7F719E5865D4</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37345BF6-4964-4B35-8DE4-0E467813B329"><gtr:id>37345BF6-4964-4B35-8DE4-0E467813B329</gtr:id><gtr:title>Additional rare variant analysis in Parkinson's disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AAD7C72D-A447-4717-A5C4-B8A11F488328"><gtr:id>AAD7C72D-A447-4717-A5C4-B8A11F488328</gtr:id><gtr:title>Parkin-related disease clinically diagnosed as a pallido-pyramidal syndrome.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/be6ea1c232be937c5290da4b55716e40"><gtr:id>be6ea1c232be937c5290da4b55716e40</gtr:id><gtr:otherNames>Wickremaratchi MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A1D81687-D343-4D2A-AB38-9B08C8BFA380"><gtr:id>A1D81687-D343-4D2A-AB38-9B08C8BFA380</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF523679-A8B7-4A86-9BF8-FD9456CE8A2A"><gtr:id>DF523679-A8B7-4A86-9BF8-FD9456CE8A2A</gtr:id><gtr:title>Psychiatric disorders, myoclonus dystonia and SGCE: an international study.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bfb676b61584161f3525a4a662573280"><gtr:id>bfb676b61584161f3525a4a662573280</gtr:id><gtr:otherNames>Peall KJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/303E9F77-D4F6-4E39-9DB7-B3575F85E905"><gtr:id>303E9F77-D4F6-4E39-9DB7-B3575F85E905</gtr:id><gtr:title>Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/5e92699e66f262cd182ee6581ab96aae"><gtr:id>5e92699e66f262cd182ee6581ab96aae</gtr:id><gtr:otherNames>H?glinger GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82A5C067-DE43-475B-B144-CA258D7FF425"><gtr:id>82A5C067-DE43-475B-B144-CA258D7FF425</gtr:id><gtr:title>Genetic risk and age in Parkinson's disease: Continuum not stratum.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9B3DF794-170E-42EB-BFCF-A07D902FC502"><gtr:id>9B3DF794-170E-42EB-BFCF-A07D902FC502</gtr:id><gtr:title>Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/754143FD-E66E-4EE7-9F82-248D2AC939A0"><gtr:id>754143FD-E66E-4EE7-9F82-248D2AC939A0</gtr:id><gtr:title>Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68ca09ebb1473b9780612d7b5d9dafef"><gtr:id>68ca09ebb1473b9780612d7b5d9dafef</gtr:id><gtr:otherNames>Wray S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/92BE1A3F-166D-4534-BEB5-B57F7C08DEF9"><gtr:id>92BE1A3F-166D-4534-BEB5-B57F7C08DEF9</gtr:id><gtr:title>Developmental regulation of tau splicing is disrupted in stem cell-derived neurons from frontotemporal dementia patients with the 10 + 16 splice-site mutation in MAPT.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b39d653d4d3c3376c5d341f10c040edc"><gtr:id>b39d653d4d3c3376c5d341f10c040edc</gtr:id><gtr:otherNames>Sposito T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BC9D5CF-4DF1-45BD-B705-34968B78F210"><gtr:id>1BC9D5CF-4DF1-45BD-B705-34968B78F210</gtr:id><gtr:title>Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0b6f56a59bf0c127ea59004421ab9871"><gtr:id>0b6f56a59bf0c127ea59004421ab9871</gtr:id><gtr:otherNames>Lubbe SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F5A01BD4-812A-4528-A05B-B954635B43AA"><gtr:id>F5A01BD4-812A-4528-A05B-B954635B43AA</gtr:id><gtr:title>Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome&amp;nbsp;9p.</gtr:title><gtr:parentPublicationTitle>Journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aa6e4c00f81ef37e11c10b421407365c"><gtr:id>aa6e4c00f81ef37e11c10b421407365c</gtr:id><gtr:otherNames>Pearson JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0340-5354</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5E2A59A-79E1-4D7C-8491-79E27362046F"><gtr:id>A5E2A59A-79E1-4D7C-8491-79E27362046F</gtr:id><gtr:title>Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a13d851deef459249d6e218a93ec16eb"><gtr:id>a13d851deef459249d6e218a93ec16eb</gtr:id><gtr:otherNames>Swallow DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D75AED70-4E63-4C47-BDD2-BEB2CDCEB8B9"><gtr:id>D75AED70-4E63-4C47-BDD2-BEB2CDCEB8B9</gtr:id><gtr:title>The effect of age and the H1c MAPT haplotype on MAPT expression in human brain.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/329dab4307ea49413869f142b920629b"><gtr:id>329dab4307ea49413869f142b920629b</gtr:id><gtr:otherNames>Hayesmoore JB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700943</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>